Global Asthma Immunotherapies Market Size, Status and Forecast 2021-2027

SKU ID :QYR-17716198 | Published Date: 18-Mar-2021 | No. of pages: 98
1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Asthma Immunotherapies Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Subcutaneous Immunotherapy 1.2.3 Sublingual Immunotherapy 1.3 Market by Application 1.3.1 Global Asthma Immunotherapies Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospital Pharmacies 1.3.3 Online Pharmacies 1.3.4 Retail Pharmacies 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Asthma Immunotherapies Market Perspective (2016-2027) 2.2 Asthma Immunotherapies Growth Trends by Regions 2.2.1 Asthma Immunotherapies Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Asthma Immunotherapies Historic Market Share by Regions (2016-2021) 2.2.3 Asthma Immunotherapies Forecasted Market Size by Regions (2022-2027) 2.3 Asthma Immunotherapies Industry Dynamic 2.3.1 Asthma Immunotherapies Market Trends 2.3.2 Asthma Immunotherapies Market Drivers 2.3.3 Asthma Immunotherapies Market Challenges 2.3.4 Asthma Immunotherapies Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Asthma Immunotherapies Players by Revenue 3.1.1 Global Top Asthma Immunotherapies Players by Revenue (2016-2021) 3.1.2 Global Asthma Immunotherapies Revenue Market Share by Players (2016-2021) 3.2 Global Asthma Immunotherapies Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Asthma Immunotherapies Revenue 3.4 Global Asthma Immunotherapies Market Concentration Ratio 3.4.1 Global Asthma Immunotherapies Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Asthma Immunotherapies Revenue in 2020 3.5 Asthma Immunotherapies Key Players Head office and Area Served 3.6 Key Players Asthma Immunotherapies Product Solution and Service 3.7 Date of Enter into Asthma Immunotherapies Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Asthma Immunotherapies Breakdown Data by Type 4.1 Global Asthma Immunotherapies Historic Market Size by Type (2016-2021) 4.2 Global Asthma Immunotherapies Forecasted Market Size by Type (2022-2027) 5 Asthma Immunotherapies Breakdown Data by Application 5.1 Global Asthma Immunotherapies Historic Market Size by Application (2016-2021) 5.2 Global Asthma Immunotherapies Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Asthma Immunotherapies Market Size (2016-2027) 6.2 North America Asthma Immunotherapies Market Size by Type 6.2.1 North America Asthma Immunotherapies Market Size by Type (2016-2021) 6.2.2 North America Asthma Immunotherapies Market Size by Type (2022-2027) 6.2.3 North America Asthma Immunotherapies Market Size by Type (2016-2027) 6.3 North America Asthma Immunotherapies Market Size by Application 6.3.1 North America Asthma Immunotherapies Market Size by Application (2016-2021) 6.3.2 North America Asthma Immunotherapies Market Size by Application (2022-2027) 6.3.3 North America Asthma Immunotherapies Market Size by Application (2016-2027) 6.4 North America Asthma Immunotherapies Market Size by Country 6.4.1 North America Asthma Immunotherapies Market Size by Country (2016-2021) 6.4.2 North America Asthma Immunotherapies Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Asthma Immunotherapies Market Size (2016-2027) 7.2 Europe Asthma Immunotherapies Market Size by Type 7.2.1 Europe Asthma Immunotherapies Market Size by Type (2016-2021) 7.2.2 Europe Asthma Immunotherapies Market Size by Type (2022-2027) 7.2.3 Europe Asthma Immunotherapies Market Size by Type (2016-2027) 7.3 Europe Asthma Immunotherapies Market Size by Application 7.3.1 Europe Asthma Immunotherapies Market Size by Application (2016-2021) 7.3.2 Europe Asthma Immunotherapies Market Size by Application (2022-2027) 7.3.3 Europe Asthma Immunotherapies Market Size by Application (2016-2027) 7.4 Europe Asthma Immunotherapies Market Size by Country 7.4.1 Europe Asthma Immunotherapies Market Size by Country (2016-2021) 7.4.2 Europe Asthma Immunotherapies Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Asthma Immunotherapies Market Size (2016-2027) 8.2 Asia-Pacific Asthma Immunotherapies Market Size by Type 8.2.1 Asia-Pacific Asthma Immunotherapies Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Asthma Immunotherapies Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Asthma Immunotherapies Market Size by Type (2016-2027) 8.3 Asia-Pacific Asthma Immunotherapies Market Size by Application 8.3.1 Asia-Pacific Asthma Immunotherapies Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Asthma Immunotherapies Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Asthma Immunotherapies Market Size by Application (2016-2027) 8.4 Asia-Pacific Asthma Immunotherapies Market Size by Region 8.4.1 Asia-Pacific Asthma Immunotherapies Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Asthma Immunotherapies Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Asthma Immunotherapies Market Size (2016-2027) 9.2 Latin America Asthma Immunotherapies Market Size by Type 9.2.1 Latin America Asthma Immunotherapies Market Size by Type (2016-2021) 9.2.2 Latin America Asthma Immunotherapies Market Size by Type (2022-2027) 9.2.3 Latin America Asthma Immunotherapies Market Size by Type (2016-2027) 9.3 Latin America Asthma Immunotherapies Market Size by Application 9.3.1 Latin America Asthma Immunotherapies Market Size by Application (2016-2021) 9.3.2 Latin America Asthma Immunotherapies Market Size by Application (2022-2027) 9.3.3 Latin America Asthma Immunotherapies Market Size by Application (2016-2027) 9.4 Latin America Asthma Immunotherapies Market Size by Country 9.4.1 Latin America Asthma Immunotherapies Market Size by Country (2016-2021) 9.4.2 Latin America Asthma Immunotherapies Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Asthma Immunotherapies Market Size (2016-2027) 10.2 Middle East & Africa Asthma Immunotherapies Market Size by Type 10.2.1 Middle East & Africa Asthma Immunotherapies Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Asthma Immunotherapies Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Asthma Immunotherapies Market Size by Type (2016-2027) 10.3 Middle East & Africa Asthma Immunotherapies Market Size by Application 10.3.1 Middle East & Africa Asthma Immunotherapies Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Asthma Immunotherapies Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Asthma Immunotherapies Market Size by Application (2016-2027) 10.4 Middle East & Africa Asthma Immunotherapies Market Size by Country 10.4.1 Middle East & Africa Asthma Immunotherapies Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Asthma Immunotherapies Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Anergis 11.1.1 Anergis Company Details 11.1.2 Anergis Business Overview 11.1.3 Anergis Asthma Immunotherapies Introduction 11.1.4 Anergis Revenue in Asthma Immunotherapies Business (2016-2021) 11.1.5 Anergis Recent Development 11.2 HAL Allergy Group 11.2.1 HAL Allergy Group Company Details 11.2.2 HAL Allergy Group Business Overview 11.2.3 HAL Allergy Group Asthma Immunotherapies Introduction 11.2.4 HAL Allergy Group Revenue in Asthma Immunotherapies Business (2016-2021) 11.2.5 HAL Allergy Group Recent Development 11.3 Merck 11.3.1 Merck Company Details 11.3.2 Merck Business Overview 11.3.3 Merck Asthma Immunotherapies Introduction 11.3.4 Merck Revenue in Asthma Immunotherapies Business (2016-2021) 11.3.5 Merck Recent Development 11.4 ALK-Abello 11.4.1 ALK-Abello Company Details 11.4.2 ALK-Abello Business Overview 11.4.3 ALK-Abello Asthma Immunotherapies Introduction 11.4.4 ALK-Abello Revenue in Asthma Immunotherapies Business (2016-2021) 11.4.5 ALK-Abello Recent Development 11.5 Stallergenes Greer 11.5.1 Stallergenes Greer Company Details 11.5.2 Stallergenes Greer Business Overview 11.5.3 Stallergenes Greer Asthma Immunotherapies Introduction 11.5.4 Stallergenes Greer Revenue in Asthma Immunotherapies Business (2016-2021) 11.5.5 Stallergenes Greer Recent Development 11.6 Laboratorios LETI 11.6.1 Laboratorios LETI Company Details 11.6.2 Laboratorios LETI Business Overview 11.6.3 Laboratorios LETI Asthma Immunotherapies Introduction 11.6.4 Laboratorios LETI Revenue in Asthma Immunotherapies Business (2016-2021) 11.6.5 Laboratorios LETI Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details
List of Tables Table 1. Global Asthma Immunotherapies Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Subcutaneous Immunotherapy Table 3. Key Players of Sublingual Immunotherapy Table 4. Global Asthma Immunotherapies Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 5. Global Asthma Immunotherapies Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Asthma Immunotherapies Market Size by Regions (2016-2021) & (US$ Million) Table 7. Global Asthma Immunotherapies Market Share by Regions (2016-2021) Table 8. Global Asthma Immunotherapies Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 9. Global Asthma Immunotherapies Market Share by Regions (2022-2027) Table 10. Asthma Immunotherapies Market Trends Table 11. Asthma Immunotherapies Market Drivers Table 12. Asthma Immunotherapies Market Challenges Table 13. Asthma Immunotherapies Market Restraints Table 14. Global Asthma Immunotherapies Revenue by Players (2016-2021) & (US$ Million) Table 15. Global Asthma Immunotherapies Market Share by Players (2016-2021) Table 16. Global Top Asthma Immunotherapies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Asthma Immunotherapies as of 2020) Table 17. Ranking of Global Top Asthma Immunotherapies Companies by Revenue (US$ Million) in 2020 Table 18. Global 5 Largest Players Market Share by Asthma Immunotherapies Revenue (CR5 and HHI) & (2016-2021) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Asthma Immunotherapies Product Solution and Service Table 21. Date of Enter into Asthma Immunotherapies Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Asthma Immunotherapies Market Size by Type (2016-2021) (US$ Million) Table 24. Global Asthma Immunotherapies Revenue Market Share by Type (2016-2021) Table 25. Global Asthma Immunotherapies Forecasted Market Size by Type (2022-2027) (US$ Million) Table 26. Global Asthma Immunotherapies Revenue Market Share by Type (2022-2027) & (US$ Million) Table 27. Global Asthma Immunotherapies Market Size Share by Application (2016-2021) & (US$ Million) Table 28. Global Asthma Immunotherapies Revenue Market Share by Application (2016-2021) Table 29. Global Asthma Immunotherapies Forecasted Market Size by Application (2022-2027) (US$ Million) Table 30. Global Asthma Immunotherapies Revenue Market Share by Application (2022-2027) & (US$ Million) Table 31. North America Asthma Immunotherapies Market Size by Type (2016-2021) (US$ Million) Table 32. North America Asthma Immunotherapies Market Size by Type (2022-2027) & (US$ Million) Table 33. North America Asthma Immunotherapies Market Size by Application (2016-2021) (US$ Million) Table 34. North America Asthma Immunotherapies Market Size by Application (2022-2027) & (US$ Million) Table 35. North America Asthma Immunotherapies Market Size by Country (2016-2021) & (US$ Million) Table 36. North America Asthma Immunotherapies Market Size by Country (2022-2027) & (US$ Million) Table 37. Europe Asthma Immunotherapies Market Size by Type (2016-2021) (US$ Million) Table 38. Europe Asthma Immunotherapies Market Size by Type (2022-2027) & (US$ Million) Table 39. Europe Asthma Immunotherapies Market Size by Application (2016-2021) (US$ Million) Table 40. Europe Asthma Immunotherapies Market Size by Application (2022-2027) & (US$ Million) Table 41. Europe Asthma Immunotherapies Market Size by Country (2016-2021) & (US$ Million) Table 42. Europe Asthma Immunotherapies Market Size by Country (2022-2027) & (US$ Million) Table 43. Asia-Pacific Asthma Immunotherapies Market Size by Type (2016-2021) (US$ Million) Table 44. Asia-Pacific Asthma Immunotherapies Market Size by Type (2022-2027) & (US$ Million) Table 45. Asia-Pacific Asthma Immunotherapies Market Size by Application (2016-2021) (US$ Million) Table 46. Asia-Pacific Asthma Immunotherapies Market Size by Application (2022-2027) & (US$ Million) Table 47. Asia-Pacific Asthma Immunotherapies Market Size by Region (2016-2021) & (US$ Million) Table 48. Asia-Pacific Asthma Immunotherapies Market Size by Region (2022-2027) & (US$ Million) Table 49. Latin America Asthma Immunotherapies Market Size by Type (2016-2021) (US$ Million) Table 50. Latin America Asthma Immunotherapies Market Size by Type (2022-2027) & (US$ Million) Table 51. Latin America Asthma Immunotherapies Market Size by Application (2016-2021) (US$ Million) Table 52. Latin America Asthma Immunotherapies Market Size by Application (2022-2027) & (US$ Million) Table 53. Latin America Asthma Immunotherapies Market Size by Country (2016-2021) & (US$ Million) Table 54. Latin America Asthma Immunotherapies Market Size by Country (2022-2027) & (US$ Million) Table 55. Middle East & Africa Asthma Immunotherapies Market Size by Type (2016-2021) (US$ Million) Table 56. Middle East & Africa Asthma Immunotherapies Market Size by Type (2022-2027) & (US$ Million) Table 57. Middle East & Africa Asthma Immunotherapies Market Size by Application (2016-2021) (US$ Million) Table 58. Middle East & Africa Asthma Immunotherapies Market Size by Application (2022-2027) & (US$ Million) Table 59. Middle East & Africa Asthma Immunotherapies Market Size by Country (2016-2021) & (US$ Million) Table 60. Middle East & Africa Asthma Immunotherapies Market Size by Country (2022-2027) & (US$ Million) Table 61. Anergis Company Details Table 62. Anergis Business Overview Table 63. Anergis Asthma Immunotherapies Product Table 64. Anergis Revenue in Asthma Immunotherapies Business (2016-2021) & (US$ Million) Table 65. Anergis Recent Development Table 66. HAL Allergy Group Company Details Table 67. HAL Allergy Group Business Overview Table 68. HAL Allergy Group Asthma Immunotherapies Product Table 69. HAL Allergy Group Revenue in Asthma Immunotherapies Business (2016-2021) & (US$ Million) Table 70. HAL Allergy Group Recent Development Table 71. Merck Company Details Table 72. Merck Business Overview Table 73. Merck Asthma Immunotherapies Product Table 74. Merck Revenue in Asthma Immunotherapies Business (2016-2021) & (US$ Million) Table 75. Merck Recent Development Table 76. ALK-Abello Company Details Table 77. ALK-Abello Business Overview Table 78. ALK-Abello Asthma Immunotherapies Product Table 79. ALK-Abello Revenue in Asthma Immunotherapies Business (2016-2021) & (US$ Million) Table 80. ALK-Abello Recent Development Table 81. Stallergenes Greer Company Details Table 82. Stallergenes Greer Business Overview Table 83. Stallergenes Greer Asthma Immunotherapies Product Table 84. Stallergenes Greer Revenue in Asthma Immunotherapies Business (2016-2021) & (US$ Million) Table 85. Stallergenes Greer Recent Development Table 86. Laboratorios LETI Company Details Table 87. Laboratorios LETI Business Overview Table 88. Laboratorios LETI Asthma Immunotherapies Product Table 89. Laboratorios LETI Revenue in Asthma Immunotherapies Business (2016-2021) & (US$ Million) Table 90. Laboratorios LETI Recent Development Table 91. Research Programs/Design for This Report Table 92. Key Data Information from Secondary Sources Table 93. Key Data Information from Primary Sources List of Figures Figure 1. Global Asthma Immunotherapies Market Share by Type: 2020 VS 2027 Figure 2. Subcutaneous Immunotherapy Features Figure 3. Sublingual Immunotherapy Features Figure 4. Global Asthma Immunotherapies Market Share by Application: 2020 VS 2027 Figure 5. Hospital Pharmacies Case Studies Figure 6. Online Pharmacies Case Studies Figure 7. Retail Pharmacies Case Studies Figure 8. Asthma Immunotherapies Report Years Considered Figure 9. Global Asthma Immunotherapies Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 10. Global Asthma Immunotherapies Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global Asthma Immunotherapies Market Share by Regions: 2020 VS 2027 Figure 12. Global Asthma Immunotherapies Market Share by Regions (2022-2027) Figure 13. Global Asthma Immunotherapies Market Share by Players in 2020 Figure 14. Global Top Asthma Immunotherapies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Asthma Immunotherapies as of 2020 Figure 15. The Top 10 and 5 Players Market Share by Asthma Immunotherapies Revenue in 2020 Figure 16. Global Asthma Immunotherapies Revenue Market Share by Type (2016-2021) Figure 17. Global Asthma Immunotherapies Revenue Market Share by Type (2022-2027) Figure 18. North America Asthma Immunotherapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 19. North America Asthma Immunotherapies Market Share by Type (2016-2027) Figure 20. North America Asthma Immunotherapies Market Share by Application (2016-2027) Figure 21. North America Asthma Immunotherapies Market Share by Country (2016-2027) Figure 22. United States Asthma Immunotherapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 23. Canada Asthma Immunotherapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Europe Asthma Immunotherapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Asthma Immunotherapies Market Share by Type (2016-2027) Figure 26. Europe Asthma Immunotherapies Market Share by Application (2016-2027) Figure 27. Europe Asthma Immunotherapies Market Share by Country (2016-2027) Figure 28. Germany Asthma Immunotherapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. France Asthma Immunotherapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. U.K. Asthma Immunotherapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. Italy Asthma Immunotherapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Russia Asthma Immunotherapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Nordic Asthma Immunotherapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Asia-Pacific Asthma Immunotherapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Asthma Immunotherapies Market Share by Type (2016-2027) Figure 36. Asia-Pacific Asthma Immunotherapies Market Share by Application (2016-2027) Figure 37. Asia-Pacific Asthma Immunotherapies Market Share by Region (2016-2027) Figure 38. China Asthma Immunotherapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Japan Asthma Immunotherapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. South Korea Asthma Immunotherapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Southeast Asia Asthma Immunotherapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. India Asthma Immunotherapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Australia Asthma Immunotherapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Latin America Asthma Immunotherapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Asthma Immunotherapies Market Share by Type (2016-2027) Figure 46. Latin America Asthma Immunotherapies Market Share by Application (2016-2027) Figure 47. Latin America Asthma Immunotherapies Market Share by Country (2016-2027) Figure 48. Mexico Asthma Immunotherapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Brazil Asthma Immunotherapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Middle East & Africa Asthma Immunotherapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Asthma Immunotherapies Market Share by Type (2016-2027) Figure 52. Middle East & Africa Asthma Immunotherapies Market Share by Application (2016-2027) Figure 53. Middle East & Africa Asthma Immunotherapies Market Share by Country (2016-2027) Figure 54. Turkey Asthma Immunotherapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Saudi Arabia Asthma Immunotherapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. UAE Asthma Immunotherapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Anergis Revenue Growth Rate in Asthma Immunotherapies Business (2016-2021) Figure 58. HAL Allergy Group Revenue Growth Rate in Asthma Immunotherapies Business (2016-2021) Figure 59. Merck Revenue Growth Rate in Asthma Immunotherapies Business (2016-2021) Figure 60. ALK-Abello Revenue Growth Rate in Asthma Immunotherapies Business (2016-2021) Figure 61. Stallergenes Greer Revenue Growth Rate in Asthma Immunotherapies Business (2016-2021) Figure 62. Laboratorios LETI Revenue Growth Rate in Asthma Immunotherapies Business (2016-2021) Figure 63. Bottom-up and Top-down Approaches for This Report Figure 64. Data Triangulation Figure 65. Key Executives Interviewed
Anergis HAL Allergy Group Merck ALK-Abello Stallergenes Greer Laboratorios LETI
  • PRICE
  • $3900
    $7800
    $5850
    Buy Now

Our Clients